›Naproxen 500 mg orally twice daily
›Maximum 1000 mg per day for maintenance; a single 1000 mg loading dose may be used
›Preferred NSAID when cardiovascular risk is the main concern
›Ketorolac for severe pain needing a parenteral drug
›Ketorolac 15 mg intravenously every 6 hours
›Use 30 mg intravenously every 6 hours only in a healthy adult under 65 years and over 50 kg with normal renal function
›Maximum 60 mg per day if aged over 65, under 50 kg or with renal impairment, otherwise 120 mg per day; maximum duration 5 days including any oral NSAID that follows
›NSAID cautions carried with the dose
›Avoid with an estimated GFR below 30 ml/min, decompensated heart failure, active peptic ulcer or GI bleeding, and after 20 weeks of pregnancy
›The combination of an NSAID with an ACE inhibitor or angiotensin receptor blocker plus a diuretic markedly raises the risk of acute kidney injury and hyperkalaemia
›Co-prescribe a proton pump inhibitor if age over 65, prior ulcer, or concurrent antiplatelet or anticoagulant
›Paracetamol
›Paracetamol 1 g orally every 6 hours
›Maximum 4 g per day; reduce to 3 g per day if weight under 50 kg, chronic alcohol use, malnutrition or hepatic impairment
›Evidence from the PACE trial shows paracetamol is no better than placebo for acute low back pain; it is retained as a low-risk adjunct and as the analgesic of choice in pregnancy
›Set the target as function and sleep rather than a pain score of zero, and state the total daily ceiling for every agent on the plan
Adjunctive, second-line and neuropathic analgesia
›Short opioid course, only for severe radicular pain not controlled by scheduled multimodal non-opioids
›Morphine for titration in the department
›Morphine 0.05 to 0.1 mg/kg intravenously, roughly 2 to 4 mg per dose
›Repeat every 10 to 15 minutes to effect
›Reduce the dose by 25 to 50 percent and lengthen the interval if age over 65, frailty or an estimated GFR below 30 ml/min
›Verify against current pediatric guideline before use in a child
›Oxycodone for a limited take-home supply
›Oxycodone 5 mg orally every 6 hours as needed
›Limit to a 3 to 5 day supply with no routine refill
›Co-prescribe a stimulant laxative such as senna 8.6 to 17.2 mg orally at night and advise it be taken from the first opioid dose
›Tramadol as an alternative weak opioid
›Tramadol 50 mg orally every 6 hours as needed
›Increase to 100 mg every 6 hours if needed and tolerated
›Maximum 400 mg per day, and maximum 300 mg per day if aged over 75; avoid with an SSRI, SNRI or a seizure disorder because of serotonin syndrome and seizure risk
›Opioid-specific caution: opioid-induced urinary retention and constipation can mask or mimic cauda equina syndrome, so re-examine perineal sensation and bladder function before attributing new retention to the drug
›Neuropathic agents, recognising limited efficacy for acute sciatica
›Gabapentin 300 mg orally at night
›Titrate by 300 mg every 1 to 3 days toward 300 to 600 mg three times daily
›Slow the titration and use 100 mg steps in older patients and when an estimated GFR is below 60 ml/min
›Maximum 3600 mg per day, reduced in proportion to renal function
›Pregabalin 75 mg orally twice daily
›Titrate to 150 mg twice daily after 1 week if needed
›Maximum 300 mg per day for this indication; reduce with renal impairment
›The PRECISE trial found pregabalin did not reduce sciatica leg pain and increased dizziness and falls, so do not start it routinely
›Combined gabapentinoid and opioid prescribing markedly increases sedation and respiratory depression and should be avoided, especially in older patients
›Amitriptyline as a night-time adjunct for radicular pain with sleep disturbance
›Amitriptyline 10 mg orally at night
›Increase to 25 mg at night after 1 to 2 weeks if tolerated
›Avoid with significant cardiac conduction disease, recent myocardial infarction, urinary retention or narrow-angle glaucoma; anticholinergic load makes it a poor choice in older adults
›Duloxetine is reasonable only for chronic musculoskeletal or neuropathic back pain, not for acute sciatica
›Duloxetine 30 mg orally daily for 1 week, then 60 mg orally daily
›Maximum 60 mg per day for this indication
›Avoid with an estimated GFR below 30 ml/min or significant hepatic impairment; do not combine with tramadol
Muscle relaxants and other symptomatic agents
›Skeletal muscle relaxants, for a short course when painful paraspinal spasm is prominent
›Cyclobenzaprine 5 mg orally three times daily
›Increase to 10 mg three times daily if needed and tolerated
›Maximum 30 mg per day; limit the course to 2 to 3 weeks
›Use 5 mg once daily and avoid in adults over 65 because of anticholinergic effects, sedation, falls and delirium; it is on the Beers list
›Methocarbamol 1500 mg orally four times daily for 48 to 72 hours
›Step down to 750 mg every 4 to 6 hours
›Maximum 6 g per day initially, then 4.5 g per day maintenance
›Preferred relaxant in older adults because it is the least anticholinergic, still at a reduced dose
›Tizanidine 2 mg orally every 6 to 8 hours as needed
›Titrate by 2 to 4 mg increments to effect
›Maximum 36 mg per day and no more than 3 doses in 24 hours
›Check liver enzymes if used beyond a short course; avoid with ciprofloxacin or fluvoxamine and with significant hepatic impairment; causes dose-related hypotension
›Diazepam is not recommended: trials show no benefit over placebo for acute low back pain or sciatica and it adds sedation, falls and dependence
›Diazepam 5 mg orally twice daily for no more than 5 days if a clinician still elects to use it, avoiding co-prescription with an opioid
›Antiemetic cover for opioid-related nausea
›Ondansetron 4 mg orally or intravenously every 8 hours as needed, maximum 16 mg per day; review the ECG for QT prolongation if other QT-prolonging drugs are co-administered
›Laxative cover whenever an opioid is prescribed
›Senna 8.6 to 17.2 mg orally at night plus docusate, or polyethylene glycol 17 g orally daily, titrated to a soft daily stool
Systemic corticosteroids and agents not routinely recommended
›Systemic corticosteroids for radiculopathy
›Not recommended for isolated axial back pain and of marginal value for acute sciatica
›If a trial is chosen for severe MRI-confirmed radiculopathy
›Prednisone 60 mg orally daily for 5 days, then taper over the following 9 days, as used in the Goldberg trial
›That trial showed a modest improvement in function, no significant improvement in pain, and no reduction in the rate of subsequent surgery
›Check capillary glucose in patients with diabetes and counsel on mood change and insomnia
›Epidural corticosteroid injection is an outpatient option for radicular pain persisting beyond 4 to 6 weeks; it gives short-term leg-pain relief without changing long-term function or surgical rates and is not an ED procedure
›Agents and interventions with a dose stated so a clinician who still elects them has the number
›Intravenous or intramuscular methylprednisolone as a single ED "back pain shot", for example methylprednisolone 80 to 160 mg intramuscularly, is not supported by evidence for disc herniation and is discouraged
›Systemic antibiotics such as amoxicillin-clavulanate 875/125 mg orally twice daily have no role unless spinal or another infection is confirmed
›Benzodiazepines beyond the single relaxant context above, and carisoprodol 250 to 350 mg orally four times daily, are discouraged for dependence and sedation risk
›Gabapentinoids and opioids as first-line agents; both are second-line at best for this condition
›Bed rest beyond 24 to 48 hours is harmful and should be advised against explicitly
Non-pharmacologic care, activity and interventional options
›Advice and activity
›Reassure that most disc herniations improve within 6 to 12 weeks and that the herniated fragment often resorbs on repeat imaging
›Encourage staying active and continuing ordinary activities as pain allows; avoid prolonged sitting and heavy lifting in the acute phase
›Superficial heat for the first week gives modest short-term relief
›Physical therapy
›Refer for structured physiotherapy, including a directional-preference or McKenzie-based programme and graded core and hip strengthening, starting within 2 to 4 weeks
›Nerve-gliding and postural work for cervical radiculopathy; a soft collar may be used briefly for comfort but not beyond a few days
›Other conservative measures
›Spinal manipulation has limited evidence for radiculopathy and is contraindicated with any progressive neurological deficit, suspected instability, infection or malignancy
›Traction is not recommended as it does not improve outcomes
›Address smoking, weight, sleep and mood, which modify recovery and chronicity risk
›Interventional and surgical options
›Transforaminal epidural steroid injection for persistent radicular pain after 4 to 6 weeks of conservative care
›Microdiscectomy or open discectomy for radicular pain persisting beyond 6 to 12 weeks despite conservative care, or earlier for a significant or progressive motor deficit
›The SPORT trial and the Leiden sciatica trial show earlier surgery relieves leg pain faster, with outcomes converging with conservative care by 1 to 2 years for non-emergent cases, so the decision is preference-sensitive
›Cauda equina syndrome and a severe or progressive deficit are the exceptions that require urgent surgery regardless of duration
Iatrogenic harms and procedural cautions
›The specific way routine care harms this patient
›Prescribing an opioid and a muscle relaxant and discharging a patient with early cauda equina syndrome, whose new urinary retention is then blamed on the drugs, delaying decompression and causing permanent bladder, bowel and sexual dysfunction
›NSAID-precipitated acute kidney injury in a volume-depleted older patient already on an ACE inhibitor and a diuretic
›Intubation and neuromuscular blockade
›Succinylcholine is safe within the first 48 to 72 hours of an acute deficit, but from roughly 72 hours to 6 months after significant motor denervation it can cause hyperkalaemic cardiac arrest through extrajunctional receptor upregulation; use rocuronium 1.2 mg/kg instead
›Watch the monitor for hyperkalaemia after succinylcholine, or with a stacked NSAID and ACE inhibitor in renal impairment: peaked T waves, a widening QRS, loss of P waves and a sine-wave pattern precede arrest
›Maintain manual in-line stabilisation for any suspected unstable cervical level
›Sedation and analgesia
›Deep sedation and repeated opioid boluses impair the serial neurological examination that detects an evolving syndrome; use the smallest effective dose and document the examination before escalation
›Opioid-induced constipation causes straining that transiently raises intrathecal pressure and worsens radicular pain
›Fluids and oxygen
›There is no therapeutic role for fluid loading; excess intravenous fluid can distend the bladder and confuse the retention assessment
›Oxygen only for measured hypoxaemia; target an SpO2 of 94 to 98 percent, or 88 to 92 percent in chronic hypercapnic respiratory disease
›Vasopressors and mechanical circulatory support
›A mean arterial pressure target of 85 to 90 mmHg with vasopressors applies to acute traumatic spinal cord injury, not to atraumatic disc herniation
›Intra-aortic balloon pump and other mechanical circulatory support have no role in this condition
›Anticoagulation and fibrinolysis
›Anticoagulants and antiplatelets raise the risk of spinal epidural haematoma and must be held and, where possible, reversed before neuraxial injection or surgery, following agent-specific timing
›In an admitted immobile patient, weigh mechanical VTE prophylaxis first and delay pharmacological prophylaxis around the time of spinal surgery
›Systemic fibrinolysis given for a concurrent STEMI or ischaemic stroke can be catastrophic if there is an unrecognised epidural abscess or haematoma; factor undiagnosed spinal pathology into that risk assessment
›Analgesia-specific
›Ketorolac and other NSAIDs share the renal, GI and cardiovascular hazards above and should not be stacked with an oral NSAID
›Tramadol and duloxetine together, or either with an SSRI, risk serotonin syndrome